Pharma is looking to the over-the-counter market as an opportunity to reduce healthcare costs and promote self-administration. By creating medicines that patients choose to take, rather than have to take, forward-thinking companies can grow their market share, despite the challenging climate.
This article has been written by Dr. Thomas Hein, HERMES PHARMA and published in Innovations in Pharmaceutical Technology (IPT), December 2014 issue, pages 48-51 (Samedan Ltd).